Ricevi le ultime notizie sulle azioni Dyadic International con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di DYAI

Ultime notizie per

Dyadic International

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Dyadic International, Inc. - Common Stock

Dyadic International Inc

Earnings

News

Press Releases

Dyadic Reports First Quarter 2025 Financial Results and Highlights of Recent Company Progress

Management

Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications

Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions

Financing

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock

Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress

Dyadic to Present at Investor Conferences and BPI East

Events

Sidoti Events, LLC's Virtual September Small-Cap Conference

ASTE

CMCO

CRAI

CSE:BOIL

DAKT

DYAI

FBRT

FFAI

FMAO

FSTR

GAIA

GAMI

GLDD

HIPO

HITI

HURN

HWKN

IDCC

IIIN

KELYA

KFRC

KGEI

KINS

LICT

LXFR

MAGN

MATV

MPTI

MTUS

NMTC

ONIT

OPRT

OSPN

PKOH

PLCE

PLUS

PSTL

RELL

RLMD

ROCK

SLVM

STRR

UXIN

VNCE

VREX

Adaptimmune Therapeutics plc - American Depositary Shares

Adaptimmune Therapeutics

Annovis Bio

BioAtla

CollPlant Biotechnologies Ltd. - Ordinary Shares

CollPlant Biotechnologies

Elutia

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

FibroGen

Generation Bio

Century Therapeutics, Inc. - Common Stock

Century Therapeutics

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Liminatus Pharma, Inc. - Class A Common Stock

Liminatus Pharma

Lantern Pharma

LAVA Therapeutics

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

Mural Oncology

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

Outlook Therapeutics, Inc. - Common Stock

Outlook Therapeutics

PDS Biotechnology Corporation - Common Stock

PDS Biotechnology

Pluri

Radiopharm Theranostics Limited - American Depositary Shares

Radiopharm Theranostics

RenovoRx

Senti Biosciences

Tempest Therapeutics, Inc. - Common Stock

Tempest Therapeutics

Xilio Therapeutics

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

XOMA Royalty

8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th

HC Wainwright & Co.

Comments

Dyadic International Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO